Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Midatech Pharma
Midatech Pharma
Activities:
Drug Delivery
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Andelyn Biosciences and Grace Science, LLC partner to manufacture AAV gene therapy
The partnership will seek to maximise programme efficiency, support the ongoing clinical trial and accelerate this critical therapy to patients
Teva UK and Closed Loop Medicine partner to advance personalised medicine development
SaMD platform aims to advance personalised medicine development, improve drug efficacy and patient outcomes with specific chronic conditions
Henkel facilities receive EXCiPACT certificate as suppliers of pharmaceutical excipients
The certification means Henkel meets EXCiPACT’s guidelines for good manufacturing practice (GMP) and good distribution practice (GDP)
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Research & Development
Nanofacturing consortium makes significant progress
Partners across Europe collaborate to establish a pilot line for the scale-up and production of nanopharmaceutical products
Research & Development
Midatech Pharma-led consortium wins €7.9m in funding
For project to scale-up manufacturing of gold nanoparticle-based therapeutics for diabetes and rare cancers
Research & Development
Midatech appoints Nick Robbins-Cherry as Finance Director
Strengthening the senior management team at the nanomedicines specialist
Research & Development
Midatech makes two appointments
Strengthening the Board and senior management team
You need to be a subscriber to read this article.
Click here
to find out more.
Drug Delivery
Helping the delivery of biotech-based therapies
Modern biotech-derived medicines require new methods to aid targeted delivery. Dr Sarah Houlton, looks at some of the novel nano-based technologies that are getting results
Drug Delivery
Midatech raises £10m to advance gold-nanoparticle technology
For diabetes and cancer treatment and to work to commercialise new applications in medical diagnostics and imaging
Research & Development
MidaSol Therapeutics signs research collaboration with major US pharmaceutical company
Midatech and MonoSol Rx joint venture to develop new treatment for diabetes
Subscribe now